These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6980118)

  • 1. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
    Leclerc C; Bourgeois E; Chedid L
    Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological activities of muramyl peptides.
    Bahr GM; Chedid L
    Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
    Parant M; Riveau G; Chedid L
    Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen.
    Leclerc C; Bourgeois E; Chedid L
    Immunol Commun; 1979; 8(1):55-64. PubMed ID: 311334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.
    Watson J; Whitlock C
    J Immunol; 1978 Jul; 121(1):383-9. PubMed ID: 307582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target cells for immunomodulatory action of muramyl dipeptide.
    Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
    Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain dependence of muramyl dipeptide-induced LAF(IL 1) release by murine-adherent peritoneal cells.
    Abehsira-Amar O; Damais C; Parant M; Chedid L
    J Immunol; 1985 Jan; 134(1):365-8. PubMed ID: 3871106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I; Leclerc C; Bourgeois E; Chedid L
    J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
    Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
    J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Sugimoto M; Germain RN; Chedid L; Benacerraf B
    J Immunol; 1978 Mar; 120(3):980-2. PubMed ID: 344799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human IL 2 production by MDP and derivatives.
    Leclerc C; Morin A; Deriaud E; Chedid L
    J Immunol; 1984 Oct; 133(4):1996-2000. PubMed ID: 6332144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S; Fidler IJ
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
    Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
    Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
    Castrillón LE
    Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.